• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Lobe Sciences Ltd.

News headline image
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 18, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Update
June 04, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
June 03, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
May 31, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
May 30, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
May 21, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Company Review of 2023
January 08, 2024
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Update on L-130 Clinical Program
December 07, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
December 05, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
September 14, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
June 27, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
June 07, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
News headline image
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™
May 17, 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap